1.Nosocomial Escherichia coli and Klebsiella pneumoniae Isolates in 2003-2006:Their Distribution and Resistance Analysis
Zhen WANG ; Zhicheng LIU ; Jianwei ZHUANG ; Haiqing WANG
Chinese Journal of Nosocomiology 1994;0(04):-
OBJECTIVE To review and analyze the distribution and antimicrobial resistance of nosocomial Escherichia coli and Klebsiella pneumoniae.METHODS Disk diffusion test(Kirby-Bauer)was used for anti-microbial susceptibility.Extended spectrum ?-lactamases(ESBLs)were detected by double disk synergy test and disk diffusion confirmatory test.AmpC enzyme was detected by the three dimensional assay.RESULTS The positive rate of the production of ESBLs and AmpC enzyme was 34.6% and 5.0%,respectively.The production rate of both ESBLs and AmpC enzyme positive was 2.4%.Isolated rate of ESBLs-producing strains in sputum and urine of the inpatients in respiratory ward and urinary ward was higher than others.All strains were 100% susceptible to meropenem and imipenem but resistant to 15 other antimicrobials in different degrees.CONCLUSIONS The isolated rate of ?-lactamases-producing strains is increasing year by year.These strains are multi-drug resistant.Attention must be paid to their detection and surveillance.
2.Effects of early skull repair with titanium mesh on cerebral blood flow and neurological recovery: a randomized controlled clinical trial based on CT perfusion evaluation
Yase ZHUANG ; Zhicheng FANG ; Boyi LIU ; Li CHEN ; Danfeng YU
Chinese Journal of Tissue Engineering Research 2017;21(26):4228-4233
BACKGROUND: A skull defect is inevitable after decompression treatment for traumatic brain injury. Titanium mesh as the most recognized skull repair material has good biocompatibility and has been widely used in clinical practice. However, the timing for skull repair after brain injury is still in dispute.OBJECTIVE: To compare the changes of brain perfusion and the recovery of neurological function in patients with skull defects before and after early and late-stage titanium mesh repair based on CT perfusion technique.METHODS: This was a single-center, prospective, observational clinical trial that was completed at the Taihe Hospital,Hubei University of Medicine in Hubei Province, China. Eighty-six patients with craniocerebral injury who had undergone decompression with removal of bone flap from January 2013 to January 2016 were recruited and subjected to skull repair using titanium mesh. All the patients were randomized into two groups: test group (n=40) with early skull repair within 1-3 months after decompression and control group (n=46) with late-stage skull repair within 6-12 months after decompression. CT perfusion technology was used to observe changes of brain perfusion at 3 days operatively and at 10 days postoperatively. The Barthel index was evaluated at 30 days postoperatively. The trial was registered with ClinicalTrial.gov (identifier: NCT03222297) on July 12th, 2017. The study protocol was approved by the Ethics Committee of Taihe Hospital with the approval No. 2012 (08), and performed in accordance with the Declaration of Helsinki,formulated by the World Health Organization and the hospital's ethical requirements for human research. All the patients and their families were voluntary to participate in the trial, were fully informed of the trial process, and then signed the informed consent prior to the initialization of the trial.RESULTS AND CONCLUSION: The postoperative cerebral blood volume and cerebral blood flow at the parietal cortex on the side of skull defect and at the cortex in the defect region were significantly higher in the two group than the baseline (P < 0.05), while the time to peak was lower than the baseline (P < 0.05). Compared with the control group,significantly higher cerebral blood volume and cerebral blood flow as well as shorter time to peak were observed in the test group (P < 0.05). The Barthel index of the test group was also significantly higher than that of the control group at 30 days postoepratively (P < 0.05). Overall, early skull repair with titanium mesh is helpful to improve the cerebral blood perfusion at the affected side and the recovery of neurological function. In addition, CT perfusion technology is a safe and effective method to monitor hemodynamic changes in the brain.
3.Inhibitory effect of EGCG on proliferation and HIF-1α/VEGF expression in cell line HepG2
Zhicheng ZHAO ; Li ZHUANG ; Changku JIA ; Shusen ZHENG
Chinese Journal of Pathophysiology 2010;26(4):713-720
AIM: To study the molecular mechanism of EGCG on inhibiting the growth of hepatic carcinoma. METHODS: The proliferation of hepatic cell line HepG2 cultured with different doses of EGCG was studied by MTT and suspension/adherence methods. The effect of EGCG on the expression of HIF-1α/VEGF at mRNA and protein levels in vitro and in vivo was evaluated by RT-PCR and Western blotting, respectively. The inhibition of EGCG on the growth of tumor implanted into athymic nude mice was also observed. RESULTS: The proliferation of hepatic cell line HepG2 was inhibited by EGCG in a dose-dependent manner. The expression of HIF-1α/VEGF was suppressed markedly by EGCG at protein level. However, the inhibitory effect of EGCG on the mRNA expression was only observed on VEGF, not on HIF-1α. In the animal experiment, the implanted tumor growth was inhibited by 39.8%±5.1%. CONCLUSION: EGCG suppresses the hepatic carcinoma cell growth, and interrupts the HIF-1α/VEGF signaling pathway significantly, indicating a fundamental mechanism of EGCG for inhibiting tumor growth.
4.Inhibitory effect of EGCG on proliferation and HIF-1?/VEGF expression in cell line HepG2
Zhicheng ZHAO ; Li ZHUANG ; Changku JIA ; Shusen ZHENG
Chinese Journal of Pathophysiology 1986;0(04):-
AIM:To study the molecular mechanism of EGCG on inhibiting the growth of hepatic carcinoma. METHODS: The proliferation of hepatic cell line HepG2 cultured with different doses of EGCG was studied by MTT and suspension/adherence methods. The effect of EGCG on the expression of HIF-1?/VEGF at mRNA and protein levels in vitro and in vivo was evaluated by RT-PCR and Western blotting,respectively. The inhibition of EGCG on the growth of tumor implanted into athymic nude mice was also observed. RESULTS: The proliferation of hepatic cell line HepG2 was inhibited by EGCG in a dose-dependent manner. The expression of HIF-1?/VEGF was suppressed markedly by EGCG at protein level. However,the inhibitory effect of EGCG on the mRNA expression was only observed on VEGF,not on HIF-1?. In the animal experiment,the implanted tumor growth was inhibited by 39.8%?5.1%. CONCLUSION: EGCG suppresses the hepatic carcinoma cell growth,and interrupts the HIF-1?/VEGF signaling pathway significantly,indicating a fundamental mechanism of EGCG for inhibiting tumor growth.
5.Analysis of Language Skill in Autistic Children: 300 Cases Report
Xiang ZHOU ; Qiang CHEN ; Hong CHEN ; Heyi LI ; Huijin HU ; Zhicheng ZHUANG ; Shuping ZENG
Chinese Journal of Rehabilitation Theory and Practice 2013;19(4):384-386
Objective To study the natural developing characteristics of language skill of the autistic children. Methods 300 untreated autism children were included. Their developmental characteristics of individuals were evaluated by the Psycho-Educational Profile-Revised (PEP-R). Results The developmental quotient of most children (89.33%) was less than 70. And the developmental quotient gradually decreased with age (P<0.01). The scores of language performance and language verbal were deviation (P<0.01). Conclusion Language characteristics of autistic children without treatment is abnormal in development progress and order, and the situation would be worse with age.